home / stock / pti / pti news

PTI News and Press, Yumanity Therapeutics Inc Com From 03/10/20

Stock Information
Company Name: Yumanity Therapeutics Inc Com
Stock Symbol: PTI
Market: NASDAQ
Menu
PTI PTI Quote PTI Short PTI News PTI Articles PTI Message Board
Get PTI Alerts

News, Short Squeeze, Breakout and More Instantly...
PTI - Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update

BOSTON , March 10, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (Nasdaq: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) through theratyping, today announced financial result...
PTI - Proteostasis Therapeutics Announces New Publication on the Mechanism of Action of a Novel Class of CFTR Modulators Called Amplifiers in the Journal of Cystic Fibrosis

BOSTON , Feb. 25, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced the publication of nonclinic...

PTI - Proteostasis Therapeutics and CF Europe Announce Completion of Patient Enrollment for CHOICES, the First-Ever Personalized Medicine-Based Study in Cystic Fibrosis

BOSTON , Feb. 24, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and CF Europe, the federation of 48 national CF Associa...

PTI - HEXO, NIO among premarket gainers

One Stop Systems (NASDAQ: OSS ) +56%  reports prelim results . More news on: One Stop Systems, Inc., Genprex, Inc., Akcea Therapeutics, Inc., Stocks on the move, Read more ...

PTI - Proteostasis up 6% premarket ahead of CF data presentation

Nano cap Proteostasis Therapeutics (NASDAQ: PTI ) is up  6%  premarket on modest volume ahead of a presentation of results from an ex vivo study of its cystic fibrosis transmembrane conductance regulator (CFTR) modulators in organoids from individuals with CF who are ineligible...

PTI - Proteostasis Therapeutics Announces Keystone Symposia Presentation of Organoid Study from More than 300 Adult CF Patients

BOSTON , Jan. 22, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein proc...

PTI - DDD, NVTA among premarket gainers

Adaptimmune Therapeutics PLC (NASDAQ: ADAP ) +56%  as SPEAR T-cell platform delivers initial responses in four solid tumors. More news on: Adaptimmune Therapeutics plc, Verona Pharma plc, Mereo BioPharma Group plc, Stocks on the move, Read more ...

PTI - Proteostasis Therapeutics Regulatory Update Following Scientific Advice Meeting with MHRA

BOSTON , Jan. 13, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced a regulatory update following the comp...

PTI - FCEL, MBOT, PLX and TTPH among midday movers

Gainers: Iterum Therapeutics (NASDAQ: ITRM ) +121% . More news on: Iterum Therapeutics plc, Pintec Technology Holdings Limited, PDS Biotechnology Corporation, Stocks on the move, Read more ...

PTI - Best Penny Stocks To Trade As Markets Reach New Highs?

Will These Penny Stocks Break to New Highs This Week? The stock market has been in breakout mode this week as the Santa Claus rally continued to push stocks higher on Thursday. The NASDAQ managed to break a new, all-time high and other markets around the world also saw big surges in trading mo...
Previous 10 Next 10